INDP

Indaptus Therapeutics Inc

• NASDAQ·3d ago

  Top Biotech Gainers: AKTX Rallies; GOVX Up On Ebola Concerns; SLGL Awaits Catalysts; CMMB On Watch

• Benzinga·05/21 17:05

  12 Health Care Stocks Moving In Thursday's Intraday Session

• Seeking Alpha·05/15 13:11

  Indaptus Therapeutics GAAP EPS of -$0.23

• Benzinga·05/15 11:11

  Earnings Scheduled For May 15, 2026

• Benzinga·05/15 11:10

  Indaptus Therapeutics Q1 EPS $(0.23) Beats $(1.87) Estimate

• Reuters·05/15 11:07

  Indaptus Therapeutics Q1 net loss narrows as expenses fall

• PUBT·05/15 11:01

  Indaptus net loss narrows to $2.5 million in Q1 FY26; R&D expenses drop 82% to $491,134

• Reuters·05/15 11:00

  INDAPTUS THERAPEUTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

• Benzinga·05/04 21:06

  12 Health Care Stocks Moving In Monday's After-Market Session

• Benzinga·05/01 21:05

  12 Health Care Stocks Moving In Friday's After-Market Session

• PUBT·04/24 21:01

  Indaptus amends 8-K to reflect director Johnny Fox Arrowsmith legal name change

• TipRanks·04/23 10:39

  Indaptus Therapeutics Adds Independent Directors Amid Board Refresh

• PUBT·04/20 20:06

  Indaptus Therapeutics director Qinglai Lu files initial beneficial ownership statement

• TipRanks·04/03 16:30

  Indaptus Therapeutics Names New CFO, Refreshes Board Oversight

• Reuters·04/03 16:01

  INDAPTUS THERAPEUTICS INC - APPOINTS YU DING AS CFO EFFECTIVE APRIL 1, 2026 - SEC FILING